Topic Paragraphs
First in Class Targeted Therapy Approved for Common Form of Pancreatic Cancer

New drug now FDA approved for a lethal and aggressive form of cancer – pancreatic adenocarcinoma. This authorization aligns with the Trump administration's broader initiatives to expedite breakthrough oncology treatments.

Back to Top